Gautam Sudhir Ghatnekar
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.0MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 15, 2020 | NIH | SBIR Phase II Improving marginal allograft outcomes through cell junction stabilization in transplantation | $300K | — |
| Apr 15, 2019 | NIH | SBIR Phase I Evaluation of a Novel Connexin-Based Peptide in the Treatment of Combined Ionizing Radiation and Thermal Burn Injury | $300K | — |
| Aug 17, 2017 | NIH | SBIR Phase I Evaluation of a Connexin-based Peptide for the Treatment of Age-Related Macular Degeneration | $225K | — |
| Aug 4, 2016 | NIH | SBIR Phase I Stabilization of gap/tight junctions to ameliorate brain death induced endothelial cell injury | $225K | — |
| May 4, 2016 | NIH | SBIR Phase II Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds | $997K | — |
| Jun 29, 2015 | NIH | SBIR Phase II Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds | $997K | — |
Peer ranks
Federal funding#133
Awards as PI#117
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.